Letter from the Editor: 2022

References

• Adler AJ. 2022. Cancer Immunology and Immunotherapy: From Defining Basic Immunology to Leading the Fight Against Cancer. Immunol Invest. 1–5. doi: 10.1080/08820139.2022.2144347
   PubMed Web of Science ®Google Scholar
• Alves MT, Simoes R, Pestana RMC, de Oliveira AN, Oliveira HHM, Soares CE, Sabino AP, Silva LM and Gomes KB. 2022. Interleukin-10 Levels are Associated with Doxorubicin-Related Cardiotoxicity in Breast Cancer Patients in a One-Year Follow-Up Study. Immunol Invest. 51(4): 883–98. doi: 10.1080/08820139.2021.1882486
   PubMed Web of Science ®Google Scholar
• Amirifar P, Mozdarani H, Yazdani R, Kiaei F, Moeini Shad T, Shahkarami S, Abolhassani H, Delavari S, Sohani M, Rezaei A, et al. 2021. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients. Immunol Invest. 50(2–3): 201–15. doi: 10.1080/08820139.2020.1723104
   PubMed Web of Science ®Google Scholar
• Ben Chaaben A, Ouni N, Douik H, Ayari F, Abaza H, Mamoghli T, Harzallah L, Fortier C, Boukouaci W, Krishnamoorthy R, et al. 2020. Soluble MICA and anti-MICA Antibodies as Biomarkers of Nasopharyngeal Carcinoma Disease. Immunol Invest. 49(5): 498–509. doi: 10.1080/08820139.2019.1690506
   PubMed Web of Science ®Google Scholar
• Chen X, Li Y, Qin L, He R and Hu C. 2021. Neutrophil Extracellular Trapping Network Promotes the Pathogenesis of Neutrophil-associated Asthma through Macrophages. Immunol Invest. 50(5): 544–61. doi: 10.1080/08820139.2020.1778720
   PubMed Web of Science ®Google Scholar
• El-Garawani I, Hassab El-Nabi S, Gadallah M and Abdelsameea E. 2021. Association between IFN-lambda 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients. Immunol Invest. 50(1): 12–22. doi: 10.1080/08820139.2020.1722158
   PubMed Web of Science ®Google Scholar
• Farid AA, Afify NA, Alsharnoby AA, Abdelsameea E and Bedair HM. 2021. Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma. Immunol Invest. 1–11. doi: 10.1080/08820139.2021.1920609
   Web of Science ®Google Scholar
• Guo Y, Feng Y, Fan P, Yao X, Peng Y, Wang R and Kuerban G. 2022. Expression and Clinical Significance of KLRG1 and 2B4 on T Cells in the Peripheral Blood and Tumour of Patients with Cervical Cancer. Immunol Invest. 51(3): 670–87. doi: 10.1080/08820139.2020.1867567
   PubMed Web of Science ®Google Scholar
• Hofman K, Shenoy GN, Chak V and Balu-Iyer SV. 2021. Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines. Immunol Invest. 50(7): 743–79. doi: 10.1080/08820139.2021.1904977
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang M, Gui L, Wan Q, Zhong J, Bai L and He M. 2022. PCSK9 Suppresses M2-Like Tumor-Associated Macrophage Polarization by Regulating the Secretion of OX40L from Hepatocellular Carcinoma Cells. Immunol Invest. 1–16. doi: 10.1080/08820139.2022.2027439
   Web of Science ®Google Scholar
• Ichimiya S, Fujimura A, Masuda M, Masuda S, Yasumatsu R, Umebayashi M, Tanaka H, Koya N, Nakagawa S, Yew PY, et al. 2021. Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma. Immunol Invest. 1–17. doi: 10.1080/08820139.2021.1973491
   Web of Science ®Google Scholar
• Ichimiya S, Fujimura A, Masuda M, Masuda S, Yasumatsu R, Umebayashi M, Tanaka H, Koya N, Nakagawa S, Yew PY, et al. 2022. Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma. Immunol Invest. 51(5): 1498–514. doi: 10.1080/08820139.2021.1973491
   PubMed Web of Science ®Google Scholar
• Jafarinia M, Alsahebfosoul F, Salehi H, Eskandari N and Ganjalikhani-Hakemi M. 2020. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy. Immunol Invest. 49(7): 758–80. doi: 10.1080/08820139.2020.1712416
   PubMed Web of Science ®Google Scholar
• Jin Z, Lan T, Zhao Y, Du J, Chen J, Lai J, Xu L, Chen S, Zhong X, Wu X, et al. 2022. Higher TIGIT(+)CD226(-) gammadelta T cells in Patients with Acute Myeloid Leukemia. Immunol Invest. 51(1): 40–50. doi: 10.1080/08820139.2020.1806868
   PubMed Web of Science ®Google Scholar
• Kerboua KE. 2021. NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19. Immunol Invest. 50(1): 92–100. doi: 10.1080/08820139.2020.1773850
   PubMed Web of Science ®Google Scholar
• Li B and Wang B. 2022. USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression. Immunol Invest. 1–17. doi: 10.1080/08820139.2022.2083972
   PubMed Web of Science ®Google Scholar
• Liang H, Li F, Li H, Wang R and Du M. 2021. Overexpression of lncRNA HULC Attenuates Myocardial Ischemia/reperfusion Injury in Rat Models and Apoptosis of Hypoxia/reoxygenation Cardiomyocytes via Targeting miR-377-5p through NLRP3/Caspase1/IL1beta Signaling Pathway Inhibition. Immunol Invest. 50(8): 925–38. doi: 10.1080/08820139.2020.1791178
   PubMed Web of Science ®Google Scholar
• Lima CA, Jammal MP, Etchebehere RM, Murta EFC and Nomelini RS. 2020. Lymphocytes in Peritumoral Stroma: Evaluation in Epithelial Ovarian Neoplasms. Immunol Invest. 49(4): 397–405. doi: 10.1080/08820139.2019.1637435
   PubMed Web of Science ®Google Scholar
• Lin J, Chen H, Huang Y, Tang W, Zhang S and Chen Y. 2022. Lack of Association Between PDCD-1 Polymorphisms and Colorectal Cancer Risk: A Case-Control Study. Immunol Invest. 1–16. doi: 10.1080/08820139.2022.2069504
   Web of Science ®Google Scholar
• Liu Y, Duan Y, Yang N, Li B and Kong D. 2021. The TIM-3 Rs10053538 Polymorphism Is Associated with Clinical Prognosis of Colorectal Cancer. Immunol Invest. 1–11. doi: 10.1080/08820139.2021.1936011
   Web of Science ®Google Scholar
• Lotfinejad P, Asadzadeh Z, Najjary S, Somi MH, Hajiasgharzadeh K, Mokhtarzadeh A, Derakhshani A, Roshani E and Baradaran B. 2022. COVID-19 Infection: Concise Review Based on the Immunological Perspective. Immunol Invest. 51(2): 246–65. doi: 10.1080/08820139.2020.1825480
   Google Scholar
• Luo W and Yin Q. 2021. B Cell Response to Vaccination. Immunol Invest. 50(7): 780–801. doi: 10.1080/08820139.2021.1903033
   PubMed Web of Science ®Google Scholar
• Mahmoodpoor A, Sanaie S, Samadi P, Yousefi M and Nader ND. 2021. SARS-CoV-2: Unique Challenges of the Virus and Vaccines. Immunol Invest. 50(7): 802–09. doi: 10.1080/08820139.2021.1936009
   PubMed Web of Science ®Google Scholar
• Mansouri N, Marjani M, Tabarsi P, von Garnier C and Mansouri D. 2021. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature. Immunol Invest. 50(8): 884–90. doi: 10.1080/08820139.2020.1789655
   PubMed Web of Science ®Google Scholar
• Matic S, D’Souza DH, Wu T, Pangloli P and Dia VP. 2020. Bovine Milk Exosomes Affect Proliferation and Protect Macrophages against Cisplatin-Induced Cytotoxicity. Immunol Invest. 49(7): 711–25. doi: 10.1080/08820139.2020.1769647
   PubMed Web of Science ®Google Scholar
• Moaaz M, Youssry S, Moaz A and Abdelrahman M. 2020. Study of TollLike Receptor 4 Gene Polymorphisms in Colorectal Cancer: Correlation with Clinicopathological Features. Immunol Invest. 49(5): 571–84. doi: 10.1080/08820139.2020.1716787
   PubMed Web of Science ®Google Scholar
• Morisaki T, Hikichi T, Onishi H, Morisaki T, Kubo M, Hirano T, Yoshimura S, Kiyotani K and Nakamura Y. 2021. Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites. Immunol Invest. 50(5): 562–79. doi: 10.1080/08820139.2020.1778721
   PubMed Web of Science ®Google Scholar
• Neamatallah M, El-Bendary M, Elalfy H, Besheer T, El-Maksoud MA, Elhammady D, Abed S, Elegezy M, Kandeel L, Eldeib D, et al. 2020. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients. Immunol Invest. 49(4): 462–76. doi: 10.1080/08820139.2019.1673772
   PubMed Web of Science ®Google Scholar
• Nuccetelli M, Pieri M, Gisone F and Bernardini S. 2022. Combined anti-SARS-CoV-2 IgA, IgG, and IgM Detection as a Better Strategy to Prevent Second Infection Spreading Waves. Immunol Invest. 51(2): 233–45. doi: 10.1080/08820139.2020.1823407
   PubMed Web of Science ®Google Scholar
• Rodrigues ISS, Martins-Filho A, Micheli DC, Lima CA, Tavares-Murta BM, Murta EFC and Nomelini RS. 2020. IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer. Immunol Invest. 49(5): 510–21. doi: 10.1080/08820139.2019.1691222
   PubMed Web of Science ®Google Scholar
• Saleh A, Sultan A, Elashry MA, Farag A, Mortada MI, Ghannam MA, Saed AM and Ghoneem E. 2022. Association of TNF-alpha G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients. Immunol Invest. 51(3): 546–57. doi: 10.1080/08820139.2020.1851709
   PubMed Web of Science ®Google Scholar
• Wang L, Mei X, Liu X, Guo L, Yang B and Chen R. 2022. The Interleukin-33/ST2 Axis Enhances Lung-Resident CD14+ Monocyte Function in Patients with Non-Small Cell Lung Cancer. Immunol Invest. 1–16. doi: 10.1080/08820139.2022.2130075
   PubMed Web of Science ®Google Scholar
• Xu H, Qin W, Feng H, Song D, Yang X and Zhang J. 2021. Analysis of the Clinical Efficacy of Dendritic Cell -cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer. Immunol Invest. 50(6): 622–33. doi: 10.1080/08820139.2020.1781881
   PubMed Web of Science ®Google Scholar
• Yang P, Cao X, Cai H, Chen X, Zhu Y, Yang Y, An W and Jie J. 2021. Upregulation of microRNA-155 Enhanced Migration and Function of Dendritic Cells in Three-dimensional Breast Cancer Microenvironment. Immunol Invest. 50(8): 1058–71. doi: 10.1080/08820139.2020.1801721
   PubMed Web of Science ®Google Scholar
• Zhou HY, Guo B, Lufumpa E, Li XM, Chen LH, Meng X and Li BZ. 2021a. Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis. Immunol Invest. 50(4): 323–37. doi: 10.1080/08820139.2020.1714650
   PubMed Web of Science ®Google Scholar
• Zhou X, Ding X, Li H, Yang C, Ma Z, Xu G, Yang S, Zhang D, Xie X, Xin L, et al. 2021b. Upregulation of TIGIT and PD-1 in Colorectal Cancer with Mismatch-repair Deficiency. Immunol Invest. 50(4): 338–55. doi: 10.1080/08820139.2020.1758130
   PubMed Web of Science ®Google Scholar